Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obinutuzumab with CHOP vs Bendamustine in Newly Diagnosed Follicular Lymphoma Grade 3A
NCT06961500Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- May 2025
- Primary completion
- Nov 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in follicular lymphoma (FL), sponsored by Sun Yat-sen University. Planned start May 2025; status: not yet recruiting.
02
Drugs
bendamustine
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT06961500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06961500.